Antiplatelet Agents
Antiplatelet Agents is a pharmaceutical drug with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window
Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage
Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention
Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management
A Prospective muLticEnter Registry in chrONic coronARy synDrOme
Clinical Trials (10)
Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window
Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage
Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention
Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management
A Prospective muLticEnter Registry in chrONic coronARy synDrOme
Endovascular Acute Stroke Intervention - Tandem OCclusion Trial
Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus
Long Term Follow-up of Comparison of Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent Implantation
Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone
Reducing Total Cardiovascular Risk in an Urban Community
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10